M&As this week: Pragmin Prognosis, Forefront Medical Technology
Healthcare and clinical diagnostics company Pragmin Prognosis Inc plans to acquire molecular diagnostics and services company Cynogen Inc (doing business as PersonalizeDx) from genomic diagnostics company Rosetta Genomics Ltd for $2.88m.
Healthcare and clinical diagnostics company Pragmin Prognosis Inc plans to acquire molecular diagnostics and services company Cynogen Inc (doing business as PersonalizeDx) from genomic diagnostics company Rosetta Genomics Ltd for $2.88m.
Forefront Medical Technology Pte Ltd plans to acquire Seychelles-based medical device contract manufacturer Chelle Medical Limited from a group of investors for S$6.8m ($5m).
Medical Device Network Excellence Awards - Nominations Closed
Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact
Excellence in Action Awarded for Innovation in Remote Hearing Diagnostics, hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.